These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 15894926

  • 1. Expression of CDX2, cytokeratins 7 and 20 in sinonasal intestinal-type adenocarcinoma.
    Ortiz-Rey JA, Alvarez C, San Miguel P, Iglesias B, Antón I.
    Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):142-6. PubMed ID: 15894926
    [Abstract] [Full Text] [Related]

  • 2. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
    McCluggage WG, Shah R, Connolly LE, McBride HA.
    Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
    [Abstract] [Full Text] [Related]

  • 3. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype.
    Tot T.
    Med Sci Monit; 2004 May; 10(5):BR139-43. PubMed ID: 15114262
    [Abstract] [Full Text] [Related]

  • 4. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
    Bayrak R, Haltas H, Yenidunya S.
    Diagn Pathol; 2012 Jan 23; 7():9. PubMed ID: 22268990
    [Abstract] [Full Text] [Related]

  • 5. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
    Kennedy MT, Jordan RC, Berean KW, Perez-Ordoñez B.
    J Clin Pathol; 2004 Sep 23; 57(9):932-7. PubMed ID: 15333652
    [Abstract] [Full Text] [Related]

  • 6. [CK7, CK20, SOX10 and CDX2: expressions and diagnostic values in primary adenocarcinoma of the sinonasal tract].
    Yue C, Piao Y, Bai Y, Liu H, Zhang L.
    Zhonghua Yi Xue Za Zhi; 2015 Aug 11; 95(30):2447-50. PubMed ID: 26711206
    [Abstract] [Full Text] [Related]

  • 7. CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma.
    Saad RS, Silverman JF, Khalifa MA, Rowsell C.
    Appl Immunohistochem Mol Morphol; 2009 May 11; 17(3):196-201. PubMed ID: 19098678
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
    Saad RS, Cho P, Silverman JF, Liu Y.
    Am J Clin Pathol; 2004 Sep 11; 122(3):421-7. PubMed ID: 15362373
    [Abstract] [Full Text] [Related]

  • 9. CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall.
    Mazziotta RM, Borczuk AC, Powell CA, Mansukhani M.
    Appl Immunohistochem Mol Morphol; 2005 Mar 11; 13(1):55-60. PubMed ID: 15722794
    [Abstract] [Full Text] [Related]

  • 10. Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine.
    Chen ZM, Wang HL.
    Am J Surg Pathol; 2004 Oct 11; 28(10):1352-9. PubMed ID: 15371952
    [Abstract] [Full Text] [Related]

  • 11. Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes.
    Choi HR, Sturgis EM, Rashid A, DeMonte F, Luna MA, Batsakis JG, El-Naggar AK.
    Hum Pathol; 2003 Nov 11; 34(11):1101-7. PubMed ID: 14652810
    [Abstract] [Full Text] [Related]

  • 12. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
    Groisman GM, Meir A, Sabo E.
    Int J Gynecol Pathol; 2004 Jan 11; 23(1):52-7. PubMed ID: 14668551
    [Abstract] [Full Text] [Related]

  • 13. Immunophenotypic differences between intestinal-type and low-grade papillary sinonasal adenocarcinomas: an immunohistochemical study of 22 cases utilizing CDX2 and MUC2.
    Cathro HP, Mills SE.
    Am J Surg Pathol; 2004 Aug 11; 28(8):1026-32. PubMed ID: 15252308
    [Abstract] [Full Text] [Related]

  • 14. CDX-2 expression is a common event in primary intestinal-type endocervical adenocarcinoma.
    Saad RS, Ismiil N, Dubé V, Nofech-Mozes S, Khalifa MA.
    Am J Clin Pathol; 2009 Oct 11; 132(4):531-8. PubMed ID: 19762530
    [Abstract] [Full Text] [Related]

  • 15. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT.
    Cancer; 2001 Oct 25; 93(5):330-6. PubMed ID: 11668468
    [Abstract] [Full Text] [Related]

  • 16. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
    Tot T.
    Cancer; 2001 Nov 15; 92(10):2727-32. PubMed ID: 11745209
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder.
    Raspollini MR, Nesi G, Baroni G, Girardi LR, Taddei GL.
    Appl Immunohistochem Mol Morphol; 2005 Dec 15; 13(4):358-62. PubMed ID: 16280666
    [Abstract] [Full Text] [Related]

  • 18. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
    Park SY, Kim HS, Hong EK, Kim WH.
    Hum Pathol; 2002 Nov 15; 33(11):1078-85. PubMed ID: 12454811
    [Abstract] [Full Text] [Related]

  • 19. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
    Shin JH, Bae JH, Lee A, Jung CK, Yim HW, Park JS, Lee KY.
    Jpn J Clin Oncol; 2010 Mar 15; 40(3):208-13. PubMed ID: 19926591
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.